Improving U.S. Health Insurance: Market Solutions to Regulatory Challenges
Explore how market-driven reforms and reducing regulatory barriers can enhance competition, innovation, and affordability in U.S. health insurance.
Explore how market-driven reforms and reducing regulatory barriers can enhance competition, innovation, and affordability in U.S. health insurance.
Analysis of US insurance data shows no link between return-to-school policies and antibiotic use for conjunctivitis, details on measles cases, COVID-19 impacts on fertility, and benefits of Paxlovid for stroke risk reduction.
Discover key organizations like SHIP, CMS, SSA, and state insurance departments that simplify Medicare enrollment and assist beneficiaries with plan decisions and supplemental coverage.
The 2024 cancer report highlights declines in US cancer mortality through 2022, with 2020 pandemic-related diagnosis drops not persisting into 2021. Key insights for oncology insurers and providers.
The U.S. Supreme Court considers the constitutionality of the Affordable Care Act's preventive services task force appointments, impacting employer health plans and insurance compliance.
Supreme Court likely to uphold Affordable Care Act provision requiring no-cost coverage for key preventive health services, affecting insurance compliance and healthcare regulation.
The U.S. Supreme Court examines the constitutionality of ACA’s preventive care mandate appointment process, impacting coverage of essential health services under insurance plans.
New Jersey's low Medicaid reimbursement rates are causing primary care physicians to close practices, limiting healthcare access for low-income patients.
UnitedHealth Group allocated $1.7 million for executive security following the death of UnitedHealthcare CEO Brian Thompson. The high-profile incident highlights executive safety and corporate governance in the health insurance sector.
Debate over Medicaid cuts threatens healthcare access for millions, impacting racial health equity and state-funded safety nets amid potential $880M reductions.